Lyrica

Product NDC
43353-414
11-digit product format
433530414
Labeler code
43353
Product ID
43353-414_46aed802-1b67-48f3-bf67-5a1c7a49cc46
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
PREGABALIN
Dosage form
CAPSULE
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
NDA021446
Marketing category
NDA
Marketing start
2004-12-30
Marketing end
0000-00-00
Substance
PREGABALIN
Active strength
150 mg/1
DEA schedule
CV
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
43353-414-30EA - Each43353-4140970a7cb-4a27-47bc-90dd-d374156a677c12018-02-20
43353-414-46EA - Each43353-414c34aae30-eb68-400c-ba02-d377387fc4d812018-02-20
43353-414-53EA - Each43353-414af6d1aa6-fd1c-49be-a9c0-d4bea040fdde12014-05-02
43353-414-70EA - Each43353-414a304171b-05a6-46b3-bc21-69dddf5c77b912018-02-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PREGABALINACTIVE INGREDIENT55JG375S6MLYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
PREGABALINACTIVE MOIETY55JG375S6MLYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675LYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357LYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
GELATININACTIVE INGREDIENT2G86QN327LLYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XLYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3LYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
SHELLACINACTIVE INGREDIENT46N107B71OLYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JLYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJLYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
TALCINACTIVE INGREDIENT7SEV7J4R1ULYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43353-414LYRICA (PREGABALIN) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3Legacy NDC20171128_fc26526a-101c-41ca-8116-3e9e33cb1600.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
43353-414-304335304143030 CAPSULE in 1 BOTTLE, PLASTIC (43353-414-30) 30 capsule2017-11-030000-00-00NoNoCurrent
43353-414-464335304144656 CAPSULE in 1 BOTTLE, PLASTIC (43353-414-46) 56 capsule2017-11-030000-00-00NoNoCurrent
43353-414-534335304145360 CAPSULE in 1 BOTTLE, PLASTIC (43353-414-53) 60 capsule2008-12-190000-00-00NoNoCurrent
43353-414-7043353041470120 CAPSULE in 1 BOTTLE, PLASTIC (43353-414-70) 120 capsule2017-05-220000-00-00NoNoCurrent